chloroquine has been researched along with Pulsatile Tinnitus in 5 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The suggested dose of chloroquine for COVID-19 infection is considerably higher than the usual dosage for malaria treatment; therefore, it is plausible that the ototoxic effects will be greater." | 6.66 | Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review. ( Baguley, DM; Kasbekar, AV; Prayuenyong, P, 2020) |
| "Chloroquine (CQ), a 4-aminoquinoline drug, has been largely used for the treatment of rheumatoid arthritis and other connective tissue diseases." | 4.84 | Chloroquine ototoxicity. ( Bortoli, R; Santiago, M, 2007) |
| " The suggested dose of chloroquine for COVID-19 infection is considerably higher than the usual dosage for malaria treatment; therefore, it is plausible that the ototoxic effects will be greater." | 2.66 | Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review. ( Baguley, DM; Kasbekar, AV; Prayuenyong, P, 2020) |
| "Tinnitus was the first and the predominant symptom in 140 patients (89." | 1.40 | Ototoxicity in Nigeria: why it persists. ( Ahmad, BM; Bakari, A; Kokong, DD, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prayuenyong, P | 1 |
| Kasbekar, AV | 1 |
| Baguley, DM | 1 |
| Kokong, DD | 1 |
| Bakari, A | 1 |
| Ahmad, BM | 1 |
| Bortoli, R | 1 |
| Santiago, M | 1 |
| Cooke, RA | 1 |
| Shannon, J | 1 |
| Dwivedi, GS | 1 |
| Mehra, YN | 1 |
2 reviews available for chloroquine and Pulsatile Tinnitus
| Article | Year |
|---|---|
Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review.
Topics: Antimalarials; Antiviral Agents; Chloroquine; COVID-19 Drug Treatment; Emergencies; Hearing Loss; Hu | 2020 |
Chloroquine ototoxicity.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cochlea; Hearing; Hearing Loss; Humans; Ti | 2007 |
3 other studies available for chloroquine and Pulsatile Tinnitus
| Article | Year |
|---|---|
Ototoxicity in Nigeria: why it persists.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimalarials; Audiometry; Child; | 2014 |
Malaria in southeast Queensland in 1979.
Topics: Adolescent; Adult; Australia; Child; Child, Preschool; Chloroquine; Dapsone; Female; Humans; Infant; | 1980 |
Ototoxicity of chloroquine phosphate. A case report.
Topics: Chloroquine; Deafness; Humans; Male; Melanins; Middle Aged; Tinnitus; Vision Disorders | 1978 |